IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights
In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.
FDA-approved test expands options for Alzheimer's disease - Insights
Joshua Bornhorst, Ph.D., describes the new, FDA-approved Alzheimer's disease (AD) test and how it differs from Mayo Clinic Laboratories' existing AD evaluation. The laboratory will offer both tests, to ensure flexibility and options for...
New tests launched in October - Insights
In October 2021, Mayo Clinic Laboratories announced eleven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Chromium and Cobalt - Insights
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' synovial fluid testing for patients with symptoms of failed hip arthroplasty. The Food and Drug Administration recommends testing for elevated chromium and cobalt, which can indicate...
PIK3CA assay guides treatment of progressing breast cancer - Insights
Katherine Geiersbach, M.D., explains how Mayo Clinic Laboratories' PIK3CA assay informs breast cancer treatment. The assay identifies patients eligible for a certain second-line therapy when initial treatment has failed.
Embracing the transformative power of digital pathology - Insights
Mayo Clinic is harnessing the extraordinary potential of digital pathology through a robust initiative that’s using the technology to enhance patient care. Mayo’s Dermatology Department is an early adopter, and clinicians, students, and...
Live and recorded presentations featuring Q&A with subject matter experts who share lessons learned, reflect on current applications for testing, project the future of lab medicine, and provide resources for growing your laboratory.
Custom gene ordering - Insights
With Mayo Clinic Laboratories’ custom gene ordering tool, clients can create specific gene panels to meet their patient’s individual needs.
Learn about how our testing for patients with renal, bladder, and prostate cancer identifies the cancer’s genetic traits and helps direct treatment.
Pathology Services - Mayo Clinic Laboratories
The consultative practice at Mayo Clinic Laboratories excels at delivering high quality diagnostic pathology through second-opinion consultations, a robust menu of subspecialty testing and staining, and digital pathology services.